Tokushima, Japan

Kazuhiro Fukae

USPTO Granted Patents = 17 

 


Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 23(Granted Patents)


Location History:

  • Osaka, JP (2016)
  • Tokushima, JP (2007 - 2017)
  • Kyoto, JP (2018 - 2019)

Company Filing History:


Years Active: 2007-2019

where 'Filed Patents' based on already Granted Patents

17 patents (USPTO):

Title: The Innovations of Kazuhiro Fukae

Introduction

Kazuhiro Fukae, an esteemed inventor based in Tokushima, Japan, has made significant contributions to the field of biotechnology, particularly through his innovations in glycosylated polypeptides. With a remarkable portfolio of 17 patents, Fukae continues to advance medical science with his groundbreaking research and inventions.

Latest Patents

Fukae's recent patents focus on the development of glycosylated polypeptides with various therapeutic applications. One notable patent is titled "Glycosylated polypeptide and pharmaceutical composition containing same." This invention aims to provide a glycosylated polypeptide with a uniform sugar chain structure that exhibits interferon β activity. The method described involves synthesizing a glycosylated peptide fragment alongside at least two other peptide fragments, which are then linked together.

Another significant patent is "Glycosylated polypeptide and drug composition containing said polypeptide." This invention addresses the need for a glycosylated polypeptide that has an affinity for somatostatin receptors while offering improved blood stability compared to traditional somatostatins. By replacing at least one amino acid in somatostatin or its analogs with a glycosylated amino acid, Fukae has innovatively enhanced the molecule's stability and efficacy.

Career Highlights

Kazuhiro Fukae has built an impressive career through his work at leading companies such as Glytech, Inc. and Otsuka Chemical Co., Ltd. His experience in these organizations has shaped his expertise in peptide chemistry and biotechnology, enabling him to develop novel therapeutic agents that can potentially revolutionize treatments for various medical conditions.

Collaborations

Throughout his career, Fukae has collaborated with distinguished colleagues including Yasuhiro Kajihara and Katsunari Tezuka. These partnerships have facilitated knowledge exchange and creativity, resulting in a synergistic approach to innovation in the field of biomedicine.

Conclusion

Kazuhiro Fukae stands out as a prolific inventor whose contributions to glycosylated polypeptides are paving the way for new pharmaceutical compositions. With a commitment to enhancing medical treatments through innovative chemistry, his work continues to inspire future advancements in biotechnological research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…